| 摘要 |
FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: antidiabetic pharmaceutical composition comprises 5-[[4-[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]-thiazolidine-2,4-dione or its pharmaceutically acceptable salt, lactose, microcrystalline cellulose and magnesium stearate and/or talk. Composition can be made as a table, powder or capsule. Method for preparing the composition involves preparing the mixture of indicated components and direct pressing the mixture. New pharmaceutical composition exhibits the improved stability, in particular, its solid medicinal formulations. ^ EFFECT: improved and valuable pharmaceutical properties of composition. ^ 6 cl, 2 tbl, 9 ex |
